AlloVir, Inc. (ALVR)
Mar 18, 2025 - ALVR was delisted (reason merged into KLRS)
9.81
+0.39 (4.14%)
Inactive · Last trade price on Mar 18, 2025

AlloVir Statistics

Total Valuation

AlloVir has a market cap or net worth of $49.21 million. The enterprise value is -$69.08 million.

Market Cap 49.21M
Enterprise Value -69.08M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

AlloVir has 5.02 million shares outstanding.

Current Share Class 5.02M
Shares Outstanding 5.02M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 15.29%
Owned by Institutions (%) 15.05%
Float 1.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.43
P/TBV Ratio 0.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 22.63

Current Ratio 22.63
Quick Ratio 22.58
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -45.37% and return on invested capital (ROIC) is -24.11%.

Return on Equity (ROE) -45.37%
Return on Assets (ROA) -22.33%
Return on Invested Capital (ROIC) -24.11%
Return on Capital Employed (ROCE) -48.77%
Revenue Per Employee n/a
Profits Per Employee -$9.79M
Employee Count 6
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.24% in the last 52 weeks. The beta is 0.62, so AlloVir's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change -45.24%
50-Day Moving Average 9.78
200-Day Moving Average 14.77
Relative Strength Index (RSI) 50.87
Average Volume (20 Days) 8,869

Short Selling Information

The latest short interest is 64,613, so 1.29% of the outstanding shares have been sold short.

Short Interest 64,613
Short Previous Month 59,532
Short % of Shares Out 1.29%
Short % of Float 3.73%
Short Ratio (days to cover) 26.44

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -55.26M
Pretax Income -179.66M
Net Income -58.77M
EBITDA -54.86M
EBIT -55.26M
Earnings Per Share (EPS) -$11.73
Full Income Statement

Balance Sheet

The company has $118.29 million in cash and n/a in debt, giving a net cash position of $118.29 million or $23.58 per share.

Cash & Cash Equivalents 118.29M
Total Debt n/a
Net Cash 118.29M
Net Cash Per Share $23.58
Equity (Book Value) 113.31M
Book Value Per Share 22.60
Working Capital 113.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -67.71M
Capital Expenditures n/a
Free Cash Flow -67.71M
FCF Per Share -$13.50
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AlloVir does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -119.42%
FCF Yield -137.58%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 16, 2025. It was a reverse split with a ratio of 0.0434783:1.

Last Split Date Jan 16, 2025
Split Type Reverse
Split Ratio 0.0434783:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a